Literature DB >> 7784085

Cloning and characterization of cbl-b: a SH3 binding protein with homology to the c-cbl proto-oncogene.

M M Keane1, O M Rivero-Lezcano, J A Mitchell, K C Robbins, S Lipkowitz.   

Abstract

We have cloned a new gene, cbl-b, with homology to the c-cbl proto-oncogene. A large protein is predicted (approx. MW 108,000) that has a proline rich domain, a nuclear localization signal, a C3HC4 zinc finger and a putative leucine zipper. There is striking nucleotide and amino acid homology to the c-cbl proto-oncogene most notably in the structural motifs described above. Cbl-b is expressed in normal and malignant mammary epithelial cells, in a variety of normal tissues, and in hematopoietic tissue and cell lines. Cbl-b expressions is up-regulated with macrophage/monocyte differentiation of the HL60 and U937 cell lines. There is direct association of the cbl-b protein with the Src Homology 3 domains of several proteins including signaling, cytoskeletal and adaptor proteins. Our data suggest that cbl-b encodes a protein which can interact with signal transduction proteins to regulate their function or to be regulated by them. Together, cbl-b and c-cbl are members of a novel family of proto-oncogenes involved in signal transduction.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7784085

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  49 in total

Review 1.  Cbl-b in T-cell activation.

Authors:  Magdalena Paolino; Josef M Penninger
Journal:  Semin Immunopathol       Date:  2010-02-21       Impact factor: 9.623

2.  Cbl-b differentially regulates activation-induced apoptosis in T helper 1 and T helper 2 cells.

Authors:  Allison Hanlon; Sihyug Jang; Padmini Salgame
Journal:  Immunology       Date:  2005-12       Impact factor: 7.397

3.  Regulation of LFA-1-dependent inflammatory cell recruitment by Cbl-b and 14-3-3 proteins.

Authors:  Eun Young Choi; Valeria V Orlova; Susanna C Fagerholm; Susanna M Nurmi; Li Zhang; Christie M Ballantyne; Carl G Gahmberg; Triantafyllos Chavakis
Journal:  Blood       Date:  2008-01-31       Impact factor: 22.113

Review 4.  Roles of E3 ubiquitin ligases in cell adhesion and migration.

Authors:  Cai Huang
Journal:  Cell Adh Migr       Date:  2010-01-18       Impact factor: 3.405

5.  Cbl-b promotes chemotherapy-induced apoptosis in rat basophilic leukemia cells by suppressing PI3K/Akt activation and enhancing MEK/ERK activation.

Authors:  Xiujuan Qu; Yingchun Li; Jing Liu; Ling Xu; Ye Zhang; Xuejun Hu; Kezuo Hou; Yunpeng Liu
Journal:  Mol Cell Biochem       Date:  2010-02-24       Impact factor: 3.396

6.  Novel oncogenic mutations of CBL in human acute myeloid leukemia that activate growth and survival pathways depend on increased metabolism.

Authors:  Margret S Fernandes; Mamatha M Reddy; Nicole J Croteau; Christoph Walz; Henry Weisbach; Klaus Podar; Hamid Band; Martin Carroll; Andreas Reiter; Richard A Larson; Ravi Salgia; James D Griffin; Martin Sattler
Journal:  J Biol Chem       Date:  2010-07-09       Impact factor: 5.157

7.  Met kinase-dependent loss of the E3 ligase Cbl in gastric cancer.

Authors:  Andrea Z Lai; Michael Durrant; Dongmei Zuo; Colin D H Ratcliffe; Morag Park
Journal:  J Biol Chem       Date:  2012-01-18       Impact factor: 5.157

8.  The N terminus of Cbl-c regulates ubiquitin ligase activity by modulating affinity for the ubiquitin-conjugating enzyme.

Authors:  Philip E Ryan; Nina Sivadasan-Nair; Marion M Nau; Sarah Nicholas; Stanley Lipkowitz
Journal:  J Biol Chem       Date:  2010-06-04       Impact factor: 5.157

9.  Hypoxia-mediated down-regulation of miRNAs' biogenesis promotes tumor immune escape in bladder cancer.

Authors:  Y Zhao; Z Shi; Z Hao; J Zhou; C Han; R Li; Q Lv; Y Liu; C Liang
Journal:  Clin Transl Oncol       Date:  2021-02-24       Impact factor: 3.405

10.  Cbl-3-deficient mice exhibit normal epithelial development.

Authors:  Emily K Griffiths; Otto Sanchez; Pleasantine Mill; Connie Krawczyk; Carlo V Hojilla; Evelyn Rubin; Marion M Nau; Rama Khokha; Stan Lipkowitz; Chi-Chung Hui; Josef M Penninger
Journal:  Mol Cell Biol       Date:  2003-11       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.